The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study
about
Cancer and systemic inflammation: treat the tumour and treat the hostPrognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.Risk factors and long-term outcome for postoperative intra-abdominal infection after hepatectomy for hepatocellular carcinoma.Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisDiscovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancerAn inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patientsAssociation between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studySystemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognosticationModified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapyPrognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-AnalysisEffects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and CancerTransaminase Activity Predicts Survival in Patients with Head and Neck CancerUsefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosisA derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular CarcinomaNovel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma.The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers.Iron metabolism and risk of cancer in the Swedish AMORIS study.Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis.The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.Systemic inflammatory response syndrome in a patient diagnosed with high grade inflammatory triple negative breast cancer: a case report of a potentially rare paraneoplastic syndromeA Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs.Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload.Prognostic factors for gastrectomy in elderly patients with gastric cancerImpact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review.Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer.Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma.The Glasgow Prognostic Score and its variants predict mortality in living donor but not in deceased donor liver transplantation for hepatocellular carcinoma: A double-center validation study.Prognostic factors for progression-free and overall survival in advanced biliary tract cancer.Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation.Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients.
P2860
Q26858815-46FC7564-6F94-4012-B858-A5B0305F5452Q33589014-D763A2CE-B84A-4CF2-9C7B-15D3D22FFBDCQ33627283-405B0CB5-6066-4D77-AF6A-F3CC2F1338E2Q33828786-1AF322BC-02BA-4E21-9089-6C2BEBA56C49Q33829684-500FF95C-EFB2-47AA-BB1B-D0E71A3A2AA4Q34030497-AD272868-A48E-4B5F-BA8B-B4F22F1A0AA6Q34566054-CD295AF5-04EB-42B3-B94C-B52F86E36C42Q34627925-55967572-3FD7-4A33-9752-4EB7E96AE071Q34773876-3BF5914D-A08F-4C4A-BF3A-4EAAC00FD23FQ34806349-5CF99976-FACD-4591-AA04-5DF235FFA5FBQ35136980-805B9A54-C360-4421-8BE1-68DC15EE2C85Q35226677-06666E40-1C9E-41D1-9C57-D5A5034643AAQ35274923-EC5FFF00-BF6E-4538-8903-9F2D6511F6F0Q35851207-B01E259F-F73C-4F55-9563-AB7C9CB134BEQ35884531-FCB3977F-5A9A-41EA-945F-3A2D806EA20BQ36009148-7F070E95-D637-4B4E-9BE0-6EFC482B2D1BQ36079922-3F4F0FE6-5583-44B3-A897-CE832BD046E7Q36127825-934ED653-CBFA-4077-A3DF-8DA4E9251147Q36161469-7649C056-9868-460E-95FA-E2EB33A0F9A4Q36161771-C7F840CA-21AE-4D13-8AFE-148035222FD6Q36166771-902C18B1-7752-4709-8442-F37A89904C99Q36194925-2D11AA31-805A-49D7-AD0A-F13678B7A259Q36246228-84490061-8619-41DF-B999-F820884B2AA2Q36257462-5C6A4435-332E-42A7-8368-0497D331AC04Q36909373-8D8C717C-6CC3-4496-98FE-84C38A021270Q36955677-DEA95D48-541D-43C5-8876-54C5EA8580DAQ37003382-91FC1A40-A7C0-41A4-A7FF-66C6FEFDD259Q37031013-0F5979CF-8C1C-4EC5-8F0F-36C13A653B73Q37465628-6C521C16-0939-4412-B8C9-BF01181133C7Q37562609-F27BBA1B-B181-4DB8-AB4D-51DFE74017D8Q37616639-20599A90-50D3-497C-956C-BC9C60460BBCQ37694036-EBE1FD4D-6665-4C58-894C-DA1876A5371AQ37702050-EC887AB6-3D93-466A-8A8F-A5FD5946E012Q37944938-DE4EB131-814B-4601-BDCD-F3DA84324374Q38406050-8B45DCDF-ACB1-446E-99E8-FF5C1BECA8BCQ39376084-E09D7C6E-63EA-48C8-9406-78EA086B040AQ39420185-345A8EF3-ED5C-4C8A-8032-26D8E399F77EQ40413628-C65BA833-A591-4A54-B4DD-C77B5A493A17Q40500922-896D7AE4-E2A6-4123-9BB2-923CC0918048Q40507543-A2E3845C-6161-4A94-A030-BC765237F823
P2860
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The relationship between the p ...... gow Inflammation Outcome Study
@ast
The relationship between the p ...... gow Inflammation Outcome Study
@en
The relationship between the p ...... gow Inflammation Outcome Study
@nl
type
label
The relationship between the p ...... gow Inflammation Outcome Study
@ast
The relationship between the p ...... gow Inflammation Outcome Study
@en
The relationship between the p ...... gow Inflammation Outcome Study
@nl
prefLabel
The relationship between the p ...... gow Inflammation Outcome Study
@ast
The relationship between the p ...... gow Inflammation Outcome Study
@en
The relationship between the p ...... gow Inflammation Outcome Study
@nl
P2093
P2860
P356
P1476
The relationship between the p ...... gow Inflammation Outcome Study
@en
P2093
A K Foulis
D S J O'Reilly
M J Proctor
P G Horgan
S M Balmar
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605855
P407
P577
2010-08-17T00:00:00Z
P5875
P6179
1018708153